Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EASL 2023 Abstract Highlights
6
Mins
August 2023
The following selected abstracts were the pinnacle of those showcased at the European Association for the Study of the Liver (EASL)…
Read more
6
Mins
3rd August 2023
EASL 2023 Abstract Highlights
The following selected abstracts were the pinnacle of those showcased at the European Association for the Study of the Liver (EASL)…
1
Mins
4th August 2022
Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience
The definition and severity of checkpoint inhibitor-induced liver injury (ChILI) have been reported using the Common Terminology Criteria for Adverse Events (CTCAE) used in cancer therapy.
2
Mins
4th August 2022
Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibitor Immunotherapy
Checkpoint inhibitor immunotherapy (ICI) has revolutionised cancer care but is associated with immune-related toxicities, which may require ICI discontinuation and immunosuppressive therapies (IST).
1
Mins
4th August 2022
Pre-transplant Changes in Serum Protein Glycosylation Relates to Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation and Provide a Potential Prognostic Biomarker: A Proof-of-Concept Study
Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in approximately 10% of patients. Changes in protein glycosylation have been described during the development of HCC and are associated with progressive disease and early mortality.
1
Mins
5th August 2021
Prevalence and Prognostic Value of Cirrhotic Cardiomyopathy as Defined According with the Proposed New Classification
The prevalence and prognostic relevance of cirrhotic cardiomyopathy (CCM), as defined according with the new core criteria proposed in 2019…
1
Mins
5th August 2021
Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium
Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…
1
Mins
5th August 2021
MicroRNA-27a-3p Modulates FoxO1 to Induce Tumour-Like Phenotypes in Bile Ducts
The authors analyse the miR landscape of CCA and non-malignant livers to define their roles in orchestrating gene regulation and promoting CCA development.
2
Mins
5th August 2021
A MET-Agonistic Antibody Mimicking Hepatocyte Growth Factor Accelerates Liver Regeneration and Improves Survival in Mice Undergoing Carbon Tetrachloride Exposure and Partial Hepatectomy
Small-for-size syndrome (SFSS) is defined by prolonged cholestasis, coagulopathy, and ascites within the first week of liver…
Loading posts...
1
2
3
…
5
Next »